| Pharmaceutical Information |
| Drug Name |
Loracarbef |
| Drug ID |
BADD_D01316 |
| Description |
Loracarbef is a carbacephem antibiotic sometimes grouped together with the second-generation cephalosporin antibiotics. It is marketed under the trade name Lorabid. |
| Indications and Usage |
Used to treat upper respiratory tract bacterial infections, chronic bronchitis, pneumonia, sinusitis, pharyntitis and tonsillitis, skin absceses, urinary tract infections and pyelonephritis caused by E. coli, S. pyogenes, S. aureus, S. saprphyticus, S. penumoniae, H. influenzae and M. catarrhalis. |
| Marketing Status |
approved; investigational; withdrawn |
| ATC Code |
J01DC08 |
| DrugBank ID |
DB00447
|
| KEGG ID |
D00916; D08143
|
| MeSH ID |
C054920
|
| PubChem ID |
5284585
|
| TTD Drug ID |
D0E9WL
|
| NDC Product Code |
Not Available |
| UNII |
3X11EVM5SU
|
| Synonyms |
loracarbef | KT 3777 | KT-3777 | Lorabid | Lorafem | Lorax | LY 163892 | LY163892 | LY-163892 | Carbac | loracarbef monohydrate |
|
| Chemical Information |
| Molecular Formula |
C16H16ClN3O4 |
| CAS Registry Number |
76470-66-1 |
| SMILES |
C1CC(=C(N2C1C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
